Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development
Tatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 405-425
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Possible Side Effects of Polyphenols and Their Interactions with Medicines
Aleksandra Duda‐Chodak, Tomasz Tarko
Molecules (2023) Vol. 28, Iss. 6, pp. 2536-2536
Open Access | Times Cited: 98
Plant Polyphenols and Their Potential Benefits on Cardiovascular Health: A Review
Iram Iqbal, Polrat Wilairatana, Fatima Saqib, et al.
Molecules (2023) Vol. 28, Iss. 17, pp. 6403-6403
Open Access | Times Cited: 86
Harnessing the Power of Polyphenols: A New Frontier in Disease Prevention and Therapy
Mohamed El Oirdi
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 692-692
Open Access | Times Cited: 20
Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology
Mai Nagaoka, Yoshiyuki Sakai, Miki Nakajima, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116128-116128
Closed Access | Times Cited: 18
INTEDE 2.0: the metabolic roadmap of drugs
Yang Zhang, Xingang Liu, Fengcheng Li, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D1355-D1364
Open Access | Times Cited: 18
Butyric acid inhibits oxidative stress and inflammation injury in calcium oxalate nephrolithiasis by targeting CYP2C9
Zijian Zhou, Xuan Zhou, Yu Zhang, et al.
Food and Chemical Toxicology (2023) Vol. 178, pp. 113925-113925
Closed Access | Times Cited: 15
Drug and pro-drug substrates and pseudo-substrates of human butyrylcholinesterase
Patrick Masson, Zukhra Shaihutdinova, Oksana Lockridge
Biochemical Pharmacology (2023) Vol. 218, pp. 115910-115910
Closed Access | Times Cited: 13
Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method
Rolf Teschke, Gaby Danan
Medicines (2024) Vol. 11, Iss. 4, pp. 9-9
Open Access | Times Cited: 4
Diving into drug-screening: zebrafish embryos as an in vivo platform for antimicrobial drug discovery and assessment
Eva Habjan, Gina K. Schouten, Alexander Speer, et al.
FEMS Microbiology Reviews (2024) Vol. 48, Iss. 3
Open Access | Times Cited: 4
Scaling Factors to inform In Vitro-In Vivo Extrapolation from Preclinical and Livestock Animals: State of the Field and Recommendations for Development of Missing Data
A. Zimmer, Abby C. Collier
Drug Metabolism Reviews (2025), pp. 1-52
Closed Access
Precision Medication Based on the Evaluation of Drug Metabolizing Enzyme and Transporter Functions
Yanrong Ma, Jing Mu, Xueyan Gou, et al.
Precision Clinical Medicine (2025) Vol. 8, Iss. 1
Open Access
Obesity-related drug-metabolizing enzyme expression alterations in the human liver
Katarzyna Kosicka, Aleksandra Romaniuk-Drapała, Yi-Hua Sheng, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 187, pp. 118155-118155
Closed Access
Impact of miR-222-3p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation
Yoshiyuki Sakai, Tatsuki Fukami, Shinsaku Tokumitsu, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 56, pp. 101007-101007
Closed Access | Times Cited: 3
Identification of the cytochrome P450 gene AccCYP6A13 in Apis cerana cerana and its response to environmental stress
Lei Li, Zihan Gao, Qinglong Zhao, et al.
Pesticide Biochemistry and Physiology (2024) Vol. 202, pp. 105890-105890
Closed Access | Times Cited: 3
In vitro hydrolysis of areca nut xenobiotics in human liver
Vincenzo Paolillo, Mahendran Jayakumar, Colton Sheperd, et al.
Drug Metabolism and Pharmacokinetics (2024) Vol. 60, pp. 101039-101039
Open Access | Times Cited: 3
Recent insights into oxidative metabolism of quercetin: catabolic profiles, degradation pathways, catalyzing metalloenzymes and molecular mechanisms
Bin Guo, Fang Chou, Libin Huang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 5, pp. 1312-1339
Closed Access | Times Cited: 12
Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity
Xiu‐Sheng Miao, Gordon J. Dear, Claire Beaumont, et al.
Chemical Research in Toxicology (2024) Vol. 37, Iss. 5, pp. 698-710
Closed Access | Times Cited: 2
Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human Liver
Hiroyuki Ichida, Tatsuki Fukami, Keito Amai, et al.
Drug Metabolism and Disposition (2022) Vol. 51, Iss. 1, pp. 17-28
Open Access | Times Cited: 10
Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization
Michela Cantiello, Monica Carletti, Mery Giantin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3564-3564
Open Access | Times Cited: 9
In vitro deacetylation of N‐acetylserotonin by arylacetamide deacetylase
Zheping Huang, Yu Li, Keigo Konishi, et al.
Journal of Pineal Research (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 5
Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine
Keiya Hirosawa, Hijiri Fujioka, Gaku Morinaga, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 12, pp. 1569-1577
Open Access | Times Cited: 5
PPARα regulates the expression of human arylacetamide deacetylase involved in drug hydrolysis and lipid metabolism
Tomomi Morikawa, Tatsuki Fukami, Saki Gotoh-Saito, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 115010-115010
Open Access | Times Cited: 9
Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity Drug
Keiya Hirosawa, Tatsuki Fukami, Masataka Nakano, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 1016-1023
Open Access | Times Cited: 4
CYP3A Mediates an Unusual C(sp2)−C(sp3) Bond Cleavage via Ipso‐Addition of Oxygen in Drug Metabolism
Xuan Qin, Yong Wang, Qiuji Ye, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 23
Closed Access | Times Cited: 1
Regulation of human hydrolases and its implications in pharmacokinetics and pharmacodynamics
Sun Min Jung, Hao‐Jie Zhu
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 11, pp. 1139-1151
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top